Jean-Patrick Demonsang
Presidente en Demonsang Consulting SAS .
Cargos activos de Jean-Patrick Demonsang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Demonsang Consulting SAS | Presidente | - | - |
Historial de carrera de Jean-Patrick Demonsang
Antiguos cargos conocidos de Jean-Patrick Demonsang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Director/Miembro de la Junta | 10/04/2014 | 22/06/2023 |
| Independent Dir/Board Member | 10/04/2014 | 22/06/2023 | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Director Ejecutivo | 21/06/2010 | 01/01/2013 |
| Presidente | 01/09/1999 | 01/01/2013 | |
| Presidente | 01/09/1999 | 01/01/2013 | |
Natixis Venture Sélection SA
 Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Director/Miembro de la Junta | - | - |
| Genode Partners SAS | Director Ejecutivo | - | - |
| Parexi SAS | Presidente | - | - |
| G1j Ile De France | Presidente | - | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Director/Miembro de la Junta | 10/04/2014 | - |
| Independent Dir/Board Member | 10/04/2014 | - |
Formación de Jean-Patrick Demonsang.
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Estadísticas
Internacional
| Francia | 10 |
Operativa
| Chairman | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Sectorial
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Empresas privadas | 7 |
|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
Natixis Venture Sélection SA
Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Finance |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Demonsang Consulting SAS | |
| G1j Ile De France | |
| Parexi SAS | |
| Genode Partners SAS |
